Technical Analysis for QURE - uniQure N.V.

Grade Last Price % Change Price Change
grade A 39.5 -1.10% -0.44
QURE closed down 1.1 percent on Thursday, June 21, 2018, on 63 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical QURE trend table...

Date Alert Name Type % Chg
Jun 21 New Uptrend Bullish 0.00%
Jun 21 Upper Bollinger Band Walk Strength 0.00%
Jun 21 Multiple of Ten Bearish Other 0.00%
Jun 21 Inside Day Range Contraction 0.00%
Jun 21 Above Upper BB Strength 0.00%
Jun 21 Overbought Stochastic Strength 0.00%
Jun 21 Upper Bollinger Band Touch Strength 0.00%
Jun 20 New 52 Week Closing High Bullish -1.10%
Jun 20 New 52 Week High Strength -1.10%
Jun 20 Stochastic Reached Overbought Strength -1.10%

Older signals for QURE ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
uniQure BV, a biopharmaceutical company, develops gene therapies through its modular technology platform for the treatment of genetic or acquired diseases. The company offers Glybera for the treatment of patients with lipoprotein lipase deficiency, an orphan metabolic disease. It also develops a pipeline of additional adeno-associated virus (AAV) based gene therapies, including AMT-060, a gene therapy for the treatment of hemophilia B; AMT-021 for acute intermittent porphyria; AMT-110 for Sanfilippo B syndrome; and AAV2/glial cell line-derived neurotrophic factor for Parkinson's disease, as well as various programs that are in early preclinical development stage. The company has collaborations with Chiesi Farmaceutici S.p.A., Digna Biotech, Institut Pasteur, and University of California San Francisco. uniQure BV was founded in 1998 and is headquartered in Amsterdam, the Netherlands.
Is QURE a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 40.98
52 Week Low 5.75
Average Volume 386,181
200-Day Moving Average 21.3839
50-Day Moving Average 32.7634
20-Day Moving Average 36.0593
10-Day Moving Average 36.691
Average True Range 1.9741
ADX 26.12
+DI 31.83
-DI 11.86
Chandelier Exit (Long, 3 ATRs ) 35.0577
Chandelier Exit (Short, 3 ATRs ) 37.6023
Upper Bollinger Band 39.5318
Lower Bollinger Band 32.5868
Percent B (%b) 1.0
BandWidth 19.259941
MACD Line 1.7731
MACD Signal Line 1.5454
MACD Histogram 0.2277
Fundamentals Value
Market Cap 1.01 Billion
Num Shares 25.6 Million
EPS -2.82
Price-to-Earnings (P/E) Ratio -14.01
Price-to-Sales 16.30
Price-to-Book 14.70
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 41.80
Resistance 3 (R3) 42.00 41.45 41.41
Resistance 2 (R2) 41.45 40.86 41.34 41.28
Resistance 1 (R1) 40.47 40.50 40.20 40.27 41.16
Pivot Point 39.92 39.92 39.78 39.81 39.92
Support 1 (S1) 38.94 39.33 38.67 38.74 37.84
Support 2 (S2) 38.39 38.97 38.28 37.72
Support 3 (S3) 37.41 38.39 37.59
Support 4 (S4) 37.21